Galderma, Actavis Settle Generic Epiduo Suit Ahead Of Trial
Galderma Laboratories LP and Actavis Mid Atlantic LLC reached a settlement Sunday in a patent suit over Actavis' planned generic version of the acne drug Epiduo, one day before an infringement...To view the full article, register now.
Already a subscriber? Click here to view full article